Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to... see more

TSXV:BTI - Post Discussion

Bioasis Technologies Inc. > After 14 years, GET AN IND SUBMISSION IN TO THE FDA!!
View:
Post by Sniper007 on Apr 05, 2022 4:06pm

After 14 years, GET AN IND SUBMISSION IN TO THE FDA!!

Has this been discussed?

Why has there been no communication from Bioasis regarding the June 25, 2019 PR (excerpt below)? 

The Company’s lead program, xB3-001, an xB3 peptide vector trastuzumab fusion, is being readied for clinical testing for the treatment of HER2+ breast cancer brain metastases. 

In less than 3 months, it will be 3 years since that press release. How can one not believe something is happening behing the scences? xB3-001 is way too valuable to let it sit.

DrDR knows the clock is ticking.
Comment by Finallytherock on Apr 06, 2022 9:38am
LOL, this just proves my point nothing is going on and no one is really interested in their platform. sorry, the writing has been on the wall for years,
Comment by fatboy92 on Apr 06, 2022 9:55am
FTR, you have been a Member Since: July 07, 2020 there's been plenty going on since then, why did you choose this time to join Stockhouse and immediately start in with your nothing is going on bashing and if you think you have proven your point no need for you to stick around any longer. You can go save some shareholders from some other penny stock promoters. Thanks for all your concern about ...more  
Comment by prophetoffact on Apr 06, 2022 9:59am
This post has been removed in accordance with Community Policy
Comment by Sniper007 on Apr 06, 2022 10:09am
Thanks for the reminder, prophetoffact.
Comment by JDavenport on Apr 06, 2022 10:25am
Frt, I think you could better illustrate your point if you expanded your very impressive previous post, like this: zzzzzzzzzzzzzzzzzzzzzzzzzzz About xB3-001 being for sale, everything about Bioasis is for sale. Bioasis grows 'em, you eat 'em. Duh! Now that you know that, and with your extra confidence, I think you can step out and, again, expand that wondrous post. Let me do it for ...more  
Comment by Finallytherock on Apr 06, 2022 1:53pm
i am sorry you had to sell your stock for pittance just to afford basic necessities. does it upset you that the company pays zacks for their boilerplate stock promotion while they stiffed you? 
Comment by JDavenport on Apr 06, 2022 10:36am
Hey, Sdpp, in reality, everything about Bioasis has always been for sale. The strategy was to never go past phase one with anything. You gotta find some earlier stuff to copy/paste. Glossary Sdpp: An acronym for Sir_Holler, digitel, prophetoffacts, prophetoffact jd
Comment by KayakerBC on Apr 06, 2022 10:50am
....Daiichi is a leading player in Herceptin and BTI signed a collaboration with it nine months ago next week when the collaboration also expires. The payload is undisclosed; but being a leading player in Herceptin is curious. It appears to be a plausible path forward for xB3-001. We should find out, at the latest, what happened to the collaboration in the next MD&A.... Very unlikely IMO. If ...more  
Comment by JDavenport on Apr 06, 2022 11:38am
There is also the Chiesi agreement that could produce something extra. Protalix is capable of making xB3-001 using its ProCellEx plant cell manufacturing capabilities. Protalix is likely already working with Bioasis in concert with the Chiesi deal.   In the press release announcing the Chiesi/Bioasis agreement it's stated that they "have entered into a worldwide, exclusive ...more  
Comment by prophetoffact on Apr 06, 2022 11:58am
This post has been removed in accordance with Community Policy
Comment by JDavenport on Apr 06, 2022 12:21pm
No, Sdpp, whether there's an extension or not, there may be no news from Bioasis and Daiichi Sankyo. You can expect news if you want but that DS deadline is very likely more than a news deadline to satisfy you. Prothena has nothing to do with other than to teach Bioasis how not to do stuff. jd
Comment by KayakerBC on Apr 06, 2022 12:47pm
....If there is no mention of an extention of the Daiichi agreement by the time of the next financials or that they have completed their objective and are evaluating the path forward or have received more funding from Daiichi for an extention, etc., it is not a basis to assume a rosy outcome.... Neither is it a basis for assuming a bad outcome.  We could hear soon or it simply may require ...more  
Comment by JDavenport on Apr 06, 2022 1:45pm
Sdpp is setting another deadline trap. The fact is he has no idea what the terms of the Daiichi Sankyo/Bioasis agreement are, including the purpose of the deadline.  The agreement and its deadline could have many meanings as I posted earlier, including a simple demand from Bioasis to get the work done by a certain date or Bioasis is moving on. In that case, the work could be ...more  
Comment by prophetoffact on Apr 06, 2022 2:01pm
This post has been removed in accordance with Community Policy
Comment by JDavenport on Apr 06, 2022 2:27pm
No, Sdpp, I've been giving you a large number of reasons for the deadline and its possible meanings because we don't know what the deadline is for. On the other hand, you don't consider any of the possibilities. You are posting expectations of news without consideration of the various things that could be going on. You expect news. (You say!) But in reality, you're setting a ...more  
Comment by Finallytherock on Apr 06, 2022 2:07pm
lol, part of me truly feels sorry for you. i just can't imagine you believe what you write
Comment by Aarcor on Apr 06, 2022 1:44pm
My God, please tell me this is a troll post.  It can't be real, but then I just don't know because I can't tell how far below 100 SimpSnipers IQ may be.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities